0 0 0
This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited. If you don't agree, please click here.

Davies Cancer-related Breakthrough Pain

ISBN: 978-0-19-884048-0

Edition: 3rd Ed.

Publication date: May 2019

Cover: Softcover

Pages: 112 p.

Publisher: Oxford University Press

Delivery times, dependent on availability and publisher: between 2 and 14 days from when you complete the order.

Description

  • New edition of a best-selling title examining the assessment and managment of cancer-related breakthrough pain
  • Portable for quick user-friendly reference
  • 'Key Points' sections at the start of each chapter provide you with a helpful snapshot of the chapter content

New to this Edition:

  • All content has been updated to reflect current literature and research
  • Chapter 4 includes content on current controversial management ideas
  • Chapter 6 discusses content on sublingual fentnayl spray
Breakthrough pain is a common occurrence in patients with cancer pain, and is often associated with a deleterious effect on daily life, impairing quality of life substantially. It is a heterogeneous condition, and management needs to be individualized.

This valuable pocketbook discusses the clinical features of breakthrough cancer pain and the different strategies for management. It covers assessment, treatment, and reassessment. It also reviews the evidence for pharmacological interventions, like rapid onset opioids, as well as non-pharmacological interventions and disease modifying treatments.

This new edition has been thoroughly updated to account for recent developments within the field. These updates ensure that Cancer-Related Breakthrough Pain (Oxford Pain Management Library) continues to be an invaluable resource for specialists and trainees in palliative care and pain management, as well as being a quick reference guide for GPs, specialist nurses, and other healthcare professionals.